1 Study Coverage 1.1 Acute Migraine Medications Product Introduction 1.2 Market by Type 1.2.1 Global Acute Migraine Medications Market Size Growth Rate by Type 1.4.2 Triptans 1.4.3 NSAIDs 1.2.4 Others 1.3 Market by Application 1.3.1 Global Acute Migraine Medications Market Size Growth Rate by Application 1.3.2 Drug Stores 1.3.3 Hospital Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Acute Migraine Medications Sales Estimates and Forecasts 2016-2027 2.2 Global Acute Migraine Medications Revenue Estimates and Forecasts 2016-2027 2.3 Global Acute Migraine Medications Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Acute Migraine Medications Regions by Sales 2.4.1 Global Top Acute Migraine Medications Regions by Sales (2016-2021) 2.4.2 Global Top Acute Migraine Medications Regions by Sales (2022-2027) 2.5 Global Top Acute Migraine Medications Regions by Revenue 2.5.1 Global Top Acute Migraine Medications Regions by Revenue (2016-2021) 2.5.2 Global Top Acute Migraine Medications Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Acute Migraine Medications Sales by Manufacturers 3.1.1 Global Top Acute Migraine Medications Manufacturers by Sales (2016-2021) 3.1.2 Global Top Acute Migraine Medications Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Acute Migraine Medications Sales in 2020 3.2 Global Acute Migraine Medications Revenue by Manufacturers 3.2.1 Global Top Acute Migraine Medications Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Acute Migraine Medications Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Acute Migraine Medications Revenue in 2020 3.3 Global Acute Migraine Medications Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Acute Migraine Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Acute Migraine Medications Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Acute Migraine Medications Sales by Type 4.1.1 Global Acute Migraine Medications Historical Sales by Type (2016-2021) 4.1.2 Global Acute Migraine Medications Forecasted Sales by Type (2022-2027) 4.1.3 Global Acute Migraine Medications Sales Market Share by Type (2016-2027) 4.2 Global Acute Migraine Medications Revenue by Type 4.2.1 Global Acute Migraine Medications Historical Revenue by Type (2016-2021) 4.2.2 Global Acute Migraine Medications Forecasted Revenue by Type (2022-2027) 4.2.3 Global Acute Migraine Medications Revenue Market Share by Type (2016-2027) 4.3 Global Acute Migraine Medications Price by Type 4.3.1 Global Acute Migraine Medications Price by Type (2016-2021) 4.3.2 Global Acute Migraine Medications Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Acute Migraine Medications Sales by Application 5.1.1 Global Acute Migraine Medications Historical Sales by Application (2016-2021) 5.1.2 Global Acute Migraine Medications Forecasted Sales by Application (2022-2027) 5.1.3 Global Acute Migraine Medications Sales Market Share by Application (2016-2027) 5.2 Global Acute Migraine Medications Revenue by Application 5.2.1 Global Acute Migraine Medications Historical Revenue by Application (2016-2021) 5.2.2 Global Acute Migraine Medications Forecasted Revenue by Application (2022-2027) 5.2.3 Global Acute Migraine Medications Revenue Market Share by Application (2016-2027) 5.3 Global Acute Migraine Medications Price by Application 5.3.1 Global Acute Migraine Medications Price by Application (2016-2021) 5.3.2 Global Acute Migraine Medications Price Forecast by Application (2022-2027) 6 North America 6.1 North America Acute Migraine Medications Market Size by Type 6.1.1 North America Acute Migraine Medications Sales by Type (2016-2027) 6.1.2 North America Acute Migraine Medications Revenue by Type (2016-2027) 6.2 North America Acute Migraine Medications Market Size by Application 6.2.1 North America Acute Migraine Medications Sales by Application (2016-2027) 6.2.2 North America Acute Migraine Medications Revenue by Application (2016-2027) 6.3 North America Acute Migraine Medications Market Size by Country 6.3.1 North America Acute Migraine Medications Sales by Country (2016-2027) 6.3.2 North America Acute Migraine Medications Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Acute Migraine Medications Market Size by Type 7.1.1 Europe Acute Migraine Medications Sales by Type (2017-2027) 7.1.2 Europe Acute Migraine Medications Revenue by Type (2017-2027) 7.2 Europe Acute Migraine Medications Market Size by Application 7.2.1 Europe Acute Migraine Medications Sales by Application (2017-2027) 7.2.2 Europe Acute Migraine Medications Revenue by Application (2017-2027) 7.3 Europe Acute Migraine Medications Market Size by Country 7.3.1 Europe Acute Migraine Medications Sales by Country (2017-2027) 7.3.2 Europe Acute Migraine Medications Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Acute Migraine Medications Market Size by Type 8.1.1 Asia Pacific Acute Migraine Medications Sales by Type (2018-2027) 8.1.2 Asia Pacific Acute Migraine Medications Revenue by Type (2018-2027) 8.2 Asia Pacific Acute Migraine Medications Market Size by Application 8.2.1 Asia Pacific Acute Migraine Medications Sales by Application (2018-2027) 8.2.2 Asia Pacific Acute Migraine Medications Revenue by Application (2018-2027) 8.3 Asia Pacific Acute Migraine Medications Market Size by Region 8.3.1 Asia Pacific Acute Migraine Medications Sales by Region (2018-2027) 8.3.2 Asia Pacific Acute Migraine Medications Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Acute Migraine Medications Market Size by Type 9.1.1 Latin America Acute Migraine Medications Sales by Type (2019-2027) 9.1.2 Latin America Acute Migraine Medications Revenue by Type (2019-2027) 9.2 Latin America Acute Migraine Medications Market Size by Application 9.2.1 Latin America Acute Migraine Medications Sales by Application (2019-2027) 9.2.2 Latin America Acute Migraine Medications Revenue by Application (2019-2027) 9.3 Latin America Acute Migraine Medications Market Size by Country 9.3.1 Latin America Acute Migraine Medications Sales by Country (2019-2027) 9.3.2 Latin America Acute Migraine Medications Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Acute Migraine Medications Market Size by Type 6.1.1 Middle East and Africa Acute Migraine Medications Sales by Type (2016-2027) 6.1.2 Middle East and Africa Acute Migraine Medications Revenue by Type (2016-2027) 6.2 Middle East and Africa Acute Migraine Medications Market Size by Application 6.2.1 Middle East and Africa Acute Migraine Medications Sales by Application (2016-2027) 6.2.2 Middle East and Africa Acute Migraine Medications Revenue by Application (2016-2027) 6.3 Middle East and Africa Acute Migraine Medications Market Size by Country 6.3.1 Middle East and Africa Acute Migraine Medications Sales by Country (2016-2027) 6.3.2 Middle East and Africa Acute Migraine Medications Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 UAE 11 Company Profiles 11.1 GSK 11.1.1 GSK Corporation Information 11.1.2 GSK Overview 11.1.3 GSK Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 GSK Acute Migraine Medications Product Description 11.1.5 GSK Related Developments 11.2 Teva 11.2.1 Teva Corporation Information 11.2.2 Teva Overview 11.2.3 Teva Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Teva Acute Migraine Medications Product Description 11.2.5 Teva Related Developments 11.3 Pfizer 11.3.1 Pfizer Corporation Information 11.3.2 Pfizer Overview 11.3.3 Pfizer Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Pfizer Acute Migraine Medications Product Description 11.3.5 Pfizer Related Developments 11.4 Novartis 11.4.1 Novartis Corporation Information 11.4.2 Novartis Overview 11.4.3 Novartis Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Novartis Acute Migraine Medications Product Description 11.4.5 Novartis Related Developments 11.5 Merck 11.5.1 Merck Corporation Information 11.5.2 Merck Overview 11.5.3 Merck Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Merck Acute Migraine Medications Product Description 11.5.5 Merck Related Developments 11.6 Sun Pharma 11.6.1 Sun Pharma Corporation Information 11.6.2 Sun Pharma Overview 11.6.3 Sun Pharma Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Sun Pharma Acute Migraine Medications Product Description 11.6.5 Sun Pharma Related Developments 11.7 Grunenthal 11.7.1 Grunenthal Corporation Information 11.7.2 Grunenthal Overview 11.7.3 Grunenthal Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Grunenthal Acute Migraine Medications Product Description 11.7.5 Grunenthal Related Developments 11.8 Endo Pharmaceuticals 11.8.1 Endo Pharmaceuticals Corporation Information 11.8.2 Endo Pharmaceuticals Overview 11.8.3 Endo Pharmaceuticals Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Endo Pharmaceuticals Acute Migraine Medications Product Description 11.8.5 Endo Pharmaceuticals Related Developments 11.1 GSK 11.1.1 GSK Corporation Information 11.1.2 GSK Overview 11.1.3 GSK Acute Migraine Medications Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 GSK Acute Migraine Medications Product Description 11.1.5 GSK Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Acute Migraine Medications Value Chain Analysis 12.2 Acute Migraine Medications Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Acute Migraine Medications Production Mode & Process 12.4 Acute Migraine Medications Sales and Marketing 12.4.1 Acute Migraine Medications Sales Channels 12.4.2 Acute Migraine Medications Distributors 12.5 Acute Migraine Medications Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Acute Migraine Medications Industry Trends 13.2 Acute Migraine Medications Market Drivers 13.3 Acute Migraine Medications Market Challenges 13.4 Acute Migraine Medications Market Restraints 14 Key Findings in The Global Acute Migraine Medications Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Acute Migraine Medications Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Triptans Table 3. Major Manufacturers of NSAIDs Table 4. Major Manufacturers of Others Table 5. Global Acute Migraine Medications Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Acute Migraine Medications Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Acute Migraine Medications Sales by Region (2016-2021) & (K Units) Table 8. Global Acute Migraine Medications Sales Market Share by Region (2016-2021) Table 9. Global Acute Migraine Medications Sales by Region (2016-2021) & (K Units) Table 10. Global Acute Migraine Medications Sales Market Share by Region (2022-2027) Table 11. Global Acute Migraine Medications Revenue by Region (2016-2021) & (US$ Million) Table 12. Global Acute Migraine Medications Revenue Market Share by Region (2016-2021) Table 13. Global Acute Migraine Medications Revenue by Region (2022-2027) & (US$ Million) Table 14. Global Acute Migraine Medications Revenue Market Share by Region (2022-2027) Table 15. Global Acute Migraine Medications Sales by Manufacturers (2016-2021) & (K Units) Table 16. Global Acute Migraine Medications Sales Share by Manufacturers (2016-2021) Table 17. Global Acute Migraine Medications Revenue by Manufacturers (2016-2021) & (US$ Million) Table 18. Global Acute Migraine Medications Revenue Share by Manufacturers (2016-2021) Table 19. Acute Migraine Medications Price by Manufacturers 2016-2021 (US$/Unit) Table 20. Global Acute Migraine Medications Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Acute Migraine Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Migraine Medications as of 2020) Table 22. Acute Migraine Medications Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Acute Migraine Medications Product Offered Table 24. Date of Manufacturers Enter into Acute Migraine Medications Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Acute Migraine Medications Sales by Type (2016-2021) & (K Units) Table 27. Global Acute Migraine Medications Sales by Type (2022-2027) & (K Units) Table 28. Global Acute Migraine Medications Sales Share by Type (2016-2021) Table 29. Global Acute Migraine Medications Sales Share by Type (2022-2027) Table 30. Global Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million) Table 31. Global Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million) Table 32. Global Acute Migraine Medications Revenue Share by Type (2016-2021) Table 33. Global Acute Migraine Medications Revenue Share by Type (2022-2027) Table 34. Acute Migraine Medications Price by Type (2016-2021) & (US$/Unit) Table 35. Global Acute Migraine Medications Price Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Acute Migraine Medications Sales by Application (2016-2021) & (K Units) Table 37. Global Acute Migraine Medications Sales by Application (2022-2027) & (K Units) Table 38. Global Acute Migraine Medications Sales Share by Application (2016-2021) Table 39. Global Acute Migraine Medications Sales Share by Application (2022-2027) Table 40. Global Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million) Table 41. Global Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million) Table 42. Global Acute Migraine Medications Revenue Share by Application (2016-2021) Table 43. Global Acute Migraine Medications Revenue Share by Application (2022-2027) Table 44. Acute Migraine Medications Price by Application (2016-2021) & (US$/Unit) Table 45. Global Acute Migraine Medications Price Forecast by Application (2022-2027) & (US$/Unit) Table 46. North America Acute Migraine Medications Sales by Type (2016-2021) & (K Units) Table 47. North America Acute Migraine Medications Sales by Type (2022-2027) & (K Units) Table 48. North America Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million) Table 49. North America Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million) Table 50. North America Acute Migraine Medications Sales by Application (2016-2021) & (K Units) Table 51. North America Acute Migraine Medications Sales by Application (2022-2027) & (K Units) Table 52. North America Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million) Table 53. North America Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million) Table 54. North America Acute Migraine Medications Sales by Country (2016-2021) & (K Units) Table 55. North America Acute Migraine Medications Sales by Country (2022-2027) & (K Units) Table 56. North America Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million) Table 57. North America Acute Migraine Medications Revenue by Country (2022-2027) & (US$ Million) Table 58. Europe Acute Migraine Medications Sales by Type (2016-2021) & (K Units) Table 59. Europe Acute Migraine Medications Sales by Type (2022-2027) & (K Units) Table 60. Europe Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million) Table 61. Europe Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million) Table 62. Europe Acute Migraine Medications Sales by Application (2016-2021) & (K Units) Table 63. Europe Acute Migraine Medications Sales by Application (2022-2027) & (K Units) Table 64. Europe Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million) Table 65. Europe Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million) Table 66. Europe Acute Migraine Medications Sales by Country (2016-2021) & (K Units) Table 67. Europe Acute Migraine Medications Sales by Country (2022-2027) & (K Units) Table 68. Europe Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million) Table 69. Europe Acute Migraine Medications Revenue by Country (2022-2027) & (US$ Million) Table 70. Asia Pacific Acute Migraine Medications Sales by Type (2016-2021) & (K Units) Table 71. Asia Pacific Acute Migraine Medications Sales by Type (2022-2027) & (K Units) Table 72. Asia Pacific Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million) Table 73. Asia Pacific Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million) Table 74. Asia Pacific Acute Migraine Medications Sales by Application (2016-2021) & (K Units) Table 75. Asia Pacific Acute Migraine Medications Sales by Application (2022-2027) & (K Units) Table 76. Asia Pacific Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million) Table 77. Asia Pacific Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million) Table 78. Asia Pacific Acute Migraine Medications Sales by Region (2016-2021) & (K Units) Table 79. Asia Pacific Acute Migraine Medications Sales by Region (2022-2027) & (K Units) Table 80. Asia Pacific Acute Migraine Medications Revenue by Region (2016-2021) & (US$ Million) Table 81. Asia Pacific Acute Migraine Medications Revenue by Region (2022-2027) & (US$ Million) Table 82. Latin America Acute Migraine Medications Sales by Type (2016-2021) & (K Units) Table 83. Latin America Acute Migraine Medications Sales by Type (2022-2027) & (K Units) Table 84. Latin America Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million) Table 85. Latin America Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million) Table 86. Latin America Acute Migraine Medications Sales by Application (2016-2021) & (K Units) Table 87. Latin America Acute Migraine Medications Sales by Application (2022-2027) & (K Units) Table 88. Latin America Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million) Table 89. Latin America Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million) Table 90. Latin America Acute Migraine Medications Sales by Country (2016-2021) & (K Units) Table 91. Latin America Acute Migraine Medications Sales by Country (2022-2027) & (K Units) Table 92. Latin America Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million) Table 93. Latin America Acute Migraine Medications Revenue by Country (2022-2027) & (US$ Million) Table 94. Middle East and Africa Acute Migraine Medications Sales by Type (2016-2021) & (K Units) Table 95. Middle East and Africa Acute Migraine Medications Sales by Type (2022-2027) & (K Units) Table 96. Middle East and Africa Acute Migraine Medications Revenue by Type (2016-2021) & (US$ Million) Table 97. Middle East and Africa Acute Migraine Medications Revenue by Type (2022-2027) & (US$ Million) Table 98. Middle East and Africa Acute Migraine Medications Sales by Application (2016-2021) & (K Units) Table 99. Middle East and Africa Acute Migraine Medications Sales by Application (2022-2027) & (K Units) Table 100. Middle East and Africa Acute Migraine Medications Revenue by Application (2016-2021) & (US$ Million) Table 101. Middle East and Africa Acute Migraine Medications Revenue by Application (2022-2027) & (US$ Million) Table 102. Middle East and Africa Acute Migraine Medications Sales by Country (2016-2021) & (K Units) Table 103. Middle East and Africa Acute Migraine Medications Sales by Country (2022-2027) & (K Units) Table 104. Middle East and Africa Acute Migraine Medications Revenue by Country (2016-2021) & (US$ Million) Table 105. Middle East and Africa Acute Migraine Medications Revenue by Country (2022-2027) & (US$ Million) Table 106. GSK Corporation Information Table 107. GSK Description and Major Businesses Table 108. GSK Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 109. GSK Acute Migraine Medications Product Table 110. GSK Recent Developments Table 111. Teva Corporation Information Table 112. Teva Description and Major Businesses Table 113. Teva Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 114. Teva Acute Migraine Medications Product Table 115. Teva Recent Developments Table 116. Pfizer Corporation Information Table 117. Pfizer Description and Major Businesses Table 118. Pfizer Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 119. Pfizer Acute Migraine Medications Product Table 120. Pfizer Recent Developments Table 121. Novartis Corporation Information Table 122. Novartis Description and Major Businesses Table 123. Novartis Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 124. Novartis Acute Migraine Medications Product Table 125. Novartis Recent Developments Table 126. Merck Corporation Information Table 127. Merck Description and Major Businesses Table 128. Merck Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 129. Merck Acute Migraine Medications Product Table 130. Merck Recent Developments Table 131. Sun Pharma Corporation Information Table 132. Sun Pharma Description and Major Businesses Table 133. Sun Pharma Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 134. Sun Pharma Acute Migraine Medications Product Table 135. Sun Pharma Recent Developments Table 136. Grunenthal Corporation Information Table 137. Grunenthal Description and Major Businesses Table 138. Grunenthal Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 139. Grunenthal Acute Migraine Medications Product Table 140. Grunenthal Recent Developments Table 141. Endo Pharmaceuticals Corporation Information Table 142. Endo Pharmaceuticals Description and Major Businesses Table 143. Endo Pharmaceuticals Acute Migraine Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 144. Endo Pharmaceuticals Acute Migraine Medications Product Table 145. Endo Pharmaceuticals Recent Developments Table 146. Key Raw Materials Lists Table 147. Raw Materials Key Suppliers Lists Table 148. Acute Migraine Medications Distributors List Table 149. Acute Migraine Medications Customers List Table 150. Acute Migraine Medications Market Trends Table 151. Acute Migraine Medications Market Drivers Table 152. Acute Migraine Medications Market Challenges Table 153. Acute Migraine Medications Market Restraints Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Acute Migraine Medications Product Picture Figure 2. Global Acute Migraine Medications Market Share by Type in 2020 & 2027 Figure 3. Triptans Product Picture Figure 4. NSAIDs Product Picture Figure 5. Others Product Picture Figure 6. Global Acute Migraine Medications Sales Market Share by Application in 2020 & 2027 Figure 7. Drug Stores Figure 8. Hospital Pharmacies Figure 9. Acute Migraine Medications Report Years Considered Figure 10. Global Acute Migraine Medications Sales 2016-2027 (K Units) Figure 11. Global Acute Migraine Medications Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Acute Migraine Medications Revenue 2016-2027 (US$ Million) Figure 13. Global Acute Migraine Medications Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 14. Global Acute Migraine Medications Sales Market Share by Region (2016-2021) Figure 15. Global Acute Migraine Medications Sales Market Share by Region (2022-2027) Figure 16. North America Acute Migraine Medications Sales YoY (2016-2027) & (K Units) Figure 17. North America Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million) Figure 18. Europe Acute Migraine Medications Sales YoY (2016-2027) & (K Units) Figure 19. Europe Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million) Figure 20. Asia-Pacific Acute Migraine Medications Sales YoY (2016-2027) & (K Units) Figure 21. Asia-Pacific Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million) Figure 22. Latin America Acute Migraine Medications Sales YoY (2016-2027) & (K Units) Figure 23. Latin America Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million) Figure 24. Middle East & Africa Acute Migraine Medications Sales YoY (2016-2027) & (K Units) Figure 25. Middle East & Africa Acute Migraine Medications Revenue YoY (2016-2027) & (US$ Million) Figure 26. The Top 10 and Top 5 Players Market Share by Acute Migraine Medications Sales in 2020 Figure 27. The Top 10 and Top 5 Players Market Share by Acute Migraine Medications Revenue in 2020 Figure 28. Acute Migraine Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Global Acute Migraine Medications Sales Market Share by Type (2016-2027) Figure 30. Global Acute Migraine Medications Revenue Market Share by Type (2016-2027) Figure 31. Global Acute Migraine Medications Sales Market Share by Application (2016-2027) Figure 32. Global Acute Migraine Medications Revenue Market Share by Application (2016-2027) Figure 33. North America Acute Migraine Medications Sales Market Share by Type (2016-2027) Figure 34. North America Acute Migraine Medications Revenue Market Share by Type (2016-2027) Figure 35. North America Acute Migraine Medications Sales Market Share by Application (2016-2027) Figure 36. North America Acute Migraine Medications Revenue Market Share by Application (2016-2027) Figure 37. North America Acute Migraine Medications Sales Share by Country (2016-2027) Figure 38. North America Acute Migraine Medications Revenue Share by Country (2016-2027) Figure 39. U.S. Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 40. Canada Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 41. Europe Acute Migraine Medications Sales Market Share by Type (2016-2027) Figure 42. Europe Acute Migraine Medications Revenue Market Share by Type (2016-2027) Figure 43. Europe Acute Migraine Medications Sales Market Share by Application (2016-2027) Figure 44. Europe Acute Migraine Medications Revenue Market Share by Application (2016-2027) Figure 45. Europe Acute Migraine Medications Sales Share by Country (2016-2027) Figure 46. Europe Acute Migraine Medications Revenue Share by Country (2016-2027) Figure 47. Germany Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 48. France Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 49. U.K. Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 50. Italy Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 51. Russia Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 52. Asia Pacific Acute Migraine Medications Sales Market Share by Type (2016-2027) Figure 53. Asia Pacific Acute Migraine Medications Revenue Market Share by Type (2016-2027) Figure 54. Asia Pacific Acute Migraine Medications Sales Market Share by Application (2016-2027) Figure 55. Asia Pacific Acute Migraine Medications Revenue Market Share by Application (2016-2027) Figure 56. Asia Pacific Acute Migraine Medications Sales Share by Region (2016-2027) Figure 57. Asia Pacific Acute Migraine Medications Revenue Share by Region (2016-2027) Figure 58. China Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 59. Japan Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 60. South Korea Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 61. India Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 62. Australia Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 63. Taiwan Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 64. Indonesia Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 65. Thailand Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 66. Malaysia Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 67. Philippines Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 68. Latin America Acute Migraine Medications Sales Market Share by Type (2016-2027) Figure 69. Latin America Acute Migraine Medications Revenue Market Share by Type (2016-2027) Figure 70. Latin America Acute Migraine Medications Sales Market Share by Application (2016-2027) Figure 71. Latin America Acute Migraine Medications Revenue Market Share by Application (2016-2027) Figure 72. Latin America Acute Migraine Medications Sales Share by Country (2016-2027) Figure 73. Latin America Acute Migraine Medications Revenue Share by Country (2016-2027) Figure 74. Mexico Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 75. Brazil Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 76. Argentina Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 77. Middle East and Africa Acute Migraine Medications Sales Market Share by Type (2016-2027) Figure 78. Middle East and Africa Acute Migraine Medications Revenue Market Share by Type (2016-2027) Figure 79. Middle East and Africa Acute Migraine Medications Sales Market Share by Application (2016-2027) Figure 80. Middle East and Africa Acute Migraine Medications Revenue Market Share by Application (2016-2027) Figure 81. Middle East and Africa Acute Migraine Medications Sales Share by Country (2016-2027) Figure 82. Middle East and Africa Acute Migraine Medications Revenue Share by Country (2016-2027) Figure 83. Turkey Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 84. Saudi Arabia Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 85. UAE Acute Migraine Medications Revenue (2016-2027) & (US$ Million) Figure 86. Acute Migraine Medications Value Chain Figure 87. Acute Migraine Medications Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed

GSK Teva Pfizer Novartis Merck Sun Pharma Grunenthal Endo Pharmaceuticals